New label information affecting all approved protease inhibitors for treatment of HIV

"The approved protease inhibitors for the treatment of HIV-1 infection now all include the following drug-drug interaction information..."

Read more: http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm209920.htm, April 27, 2010.